Alnylam is Silence Therapeutics's biggest rival. Alnylam was founded in Cambridge, Massachusetts} in 2002. Like Silence Therapeutics, Alnylam also competes in the Biotechnology sector. Compared to Silence Therapeutics, Alnylam generates $2.2B more revenue.
Harness Therapeutics is Silence Therapeutics's #2 rival. Harness Therapeutics's headquarters is in Cambridge, England, and was founded in 2020. Like Silence Therapeutics, Harness Therapeutics also competes in the Biotechnology space. Harness Therapeutics generates 11% of Silence Therapeutics's revenue.